Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

U.S. researchers synthesize new KRAS mutant inhibitors

Dec. 15, 2020

Voronoi patents FLT3 and/or MAP4K1 and/or CDK6/cyclin D1 inhibitors

Dec. 15, 2020

Arvinas reports interim clinical data for ARV-471 and ARV-110

Dec. 15, 2020

Aravive opens enrollment in phase Ib/II study of AVB-S6-500 in clear cell renal cell carcinoma

Dec. 15, 2020

Enrollment ongoing in first-in-human study of JNJ-74856665 in AML or MDS

Dec. 15, 2020

PMD-026 shows safety and initial signs of activity in metastatic breast cancer

Dec. 14, 2020

MET no better than EMT for cancer metastases

Dec. 14, 2020

Boryung Pharmaceutical describes new PI3Kdelta and/or DNA-PK inhibitors

Dec. 14, 2020

Hinova Pharmaceuticals patents new PROTACs

Dec. 14, 2020

Novel potent PI3Kdelta inhibitors that target two different mechanisms of isoform selectivity

Dec. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...